title: Religious attendance: more cost-effective than lipitor?
authors.forename: Tom
authors.initials: T
authors.lastname: Denberg
mesh_terms: D000924:Anticholesteremic Agents / Q000191:economics* / Q000627:therapeutic use*; D000069059:Atorvastatin; D003362:Cost-Benefit Analysis; D006538:Heptanoic Acids / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000191:economics*; D011758:Pyrroles / Q000191:economics* / Q000627:therapeutic use*; D012067:Religion
chemical_list: D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin